Clinical Trials
3 trialsNCT02947061 2016-10-31
S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT00438100 2015-05-29
Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer
Japan Breast Cancer Research Network
Phase 2 Completed
NCT01849380 2013-05-08
Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer
Shandong University
Phase 4 Unknown